• Yilkal Kebede

The rise of drug-resistant bacterial infections coupled with declining antibiotic efficacy poses a substantial challenge to universal healthcare. A. baumannii is one of the most difficult ESKAPE pathogens and mechanisms that have facilitated its rise as a successful pathogen are not well studied. Acinetobacter baumannii is an emerging nosocomial pathogen involved in range of infections extending from minor soft-tissue infections to more severe infections such as ventilator-associated pneumonia and bacteraemia. A. baumannii has become resistant to most of the commonly used antibiotics and multidrug-resistant isolates are becoming a severe delinquent in the healthcare locations. In the past few years, whole-genome sequences of .200 A. baumannii isolates have been generated. Numerous strategies and molecular accouterments had been used for genetic manipulation of diverse Acinetobacter spp. The severe insidious and nosocomial nature of Acinetobacter baumannii is mainly aided by its ability to form biofilms.

Acinetobacter baumannii, Multi Drug Resistance, Disease, Bacteria

"A REVIEW: Glimpse on the Global Multi-Drug Resistant Bacterium Acinetobacter baumannii", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 6, page no.45-51, June 2019, Available :http://www.jetir.org/papers/JETIR1907Q55.pdf

"A REVIEW: Glimpse on the Global Multi-Drug Resistant Bacterium Acinetobacter baumannii", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 6, page no. pp45-51, June 2019, Available at : http://www.jetir.org/papers/JETIR1907Q55.pdf